Scientists at The Scripps Research Institute announced that they’ve come up with a way to create a more effective nicotine vaccine, which could eventually help people trying to quit smoking from relapsing. In a study published in the Journal of Medicinal Chemistry, the researchers said they discovered which is the best target of two types of nicotine, which are referred to as left-handed and right-handed. According to the institute, 99 percent of the nicotine molecules in tobacco are of the left-handed variety. A once-promising nicotine vaccine that went through clinical trials a few years ago didn’t distinguish between the two sides and ended up working in only 30 percent of test subjects. Smoking is the leading cause of eight forms of cancer, including lung and fast-moving pancreatic types of the disease, according to the National Cancer Institute. Researchers are hoping that a vaccine will create antibodies that will shut off the brain’s reward system...
đź”’ Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




